Author

Cassandra A. Rigby

University of OxfordORCID 0009-0008-6883-2803Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:plant (other)· 1 Organism:rat· 1

Frequent Co-Authors

Doris QuinkertiD· 3 shared Jordan R. BarrettiD· 3 shared Kirsty McHughiD· 3 shared Simon J. DraperiD· 3 shared Ana RodriguesiD· 2 shared Angela M. MinassianiD· 2 shared Anna Gesine HuhniD· 2 shared Barnabas G. WilliamsiD· 2 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

Doris QuinkertORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologyImmunityPeer-reviewedJun 12, 2026

Structural basis for synergistic antibody protection against the essential malaria invasion complex protein RIPR

Barnabas G. Williams, Jordan R. Barrett, Josefin Bartholdson Scott…·Simon J. Draper

The paper identifies synergistic antibody interactions against the malaria protein RIPR, showing how combinations of antibodies targeting specific domains inhibit parasite invasion.

1 citationtop 4%

plant (other)experimental assay

𝕏 PostBluesky

ImmunologybioRxivPreprintDec 26, 2025

Synergistic non-neutralizing plasma antibodies to PfRH5 drive potent malaria parasite growth inhibition

Jeffrey Marchioni, Kirsty McHugh, Jordan R. Barrett…·Jason J. Lavinder

The paper identifies synergistic non-neutralizing antibodies against PfRH5 that enhance malaria parasite growth inhibition when combined with neutralizing antibodies.

DOI 10.64898/2025.12.24.696081

humanproteomics

𝕏 PostBluesky

ImmunologyNature CommunicationsPeer-reviewedJun 7, 2024

Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex

Barnabas G. Williams, Lloyd D. W. King, David Pulido…·Simon J. Draper

This paper develops a combination malaria vaccine targeting the RCR-complex by fusing epitopes from RIPR to CyRPA, improving in vitro growth inhibition compared to RH5.1 alone.

34 citationstop 1%

ratproteomics

𝕏 PostBluesky